Peptides for trans‐blood brain barrier delivery

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)
127 Downloads (Pure)

Abstract

Trans‐blood‐brain barrier (BBB) delivery of therapeutic and diagnostic agents is a major challenge in the development of central nervous system (CNS) targeted radiopharmaceuticals. This review is an introduction to the use of peptides as delivery agents to transport cargos into the CNS. The most widely used BBB penetrating peptides are reviewed here, with a particular emphasis on the broad range of cargos delivered into the CNS using these. Cell penetrating peptides (CPPs) have been deployed as trans‐BBB delivery agents for some time; new developments in the CPP field offer exciting opportunities for the design of next generation trans‐BBB complexes. Many of the peptides highlighted here are ready to be combined with diagnostic and therapeutic radiopharmaceuticals to develop highly effective CNS targeted agents.
Original languageEnglish
Pages (from-to)237-248
Number of pages12
JournalJournal of Labelled Compounds and Radiopharmaceuticals
Volume66
Issue number9
DOIs
Publication statusPublished - Jul 2023

Bibliographical note

Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • blood–brain barrier
  • cell penetrating peptides,
  • peptides
  • radiopharmaceutical
  • radiopharmaceuticals
  • cell penetrating peptides

Fingerprint

Dive into the research topics of 'Peptides for trans‐blood brain barrier delivery'. Together they form a unique fingerprint.

Cite this